Research Programs

Ophthalmology Research

Age-related macular degeneration (AMD) is the leading cause of vision loss among people over the age of 50, affecting 20 million Americans. Stargardt’s disease is a juvenile onset form that shares similar pathology and is an orphan disease. Ichor Therapeutics is developing a portfolio of proprietary biologics to cure both of these conditions.

Learn More

Oncology Research

Ichor Therapeutics has created an assortment of patent pending technologies in the field of oncology, including drug candidates, diagnostic tests, and a high-throughput drug screening platform. The company predominantly focuses on acute myeloid leukemia (AML), a blood cancer with approximately 50,000 new cases per year and a 5-year survival of only 24%.

Learn More


Partners & Clients;Friends

Relationships define success.

Our partners, clients, and friends are an extension of our company and the Ichor team. As an organization, we have aligned ourselves with leading corporations, non-profit organizations, government agencies, thought leaders, and generally useful people who share our passion for advancing standard of care for chronic disease.

Blog, Press, News


Accountability • Transparency • Integrity

The Ichor team represents the best of a new breed of researchers who share a commitment to deliver on the promise of medical biotechnology. Guided by the experience of its seasoned pharmaceutical professionals and advisors, our company culture promotes accountability, transparency, and integrity in the design and execution of our programs.

Meet The Team